The global ear infection treatment market is expected to grow at a CAGR of around 8.5% from 2021 to 2028 and expected to reach the market value of around US$ 9.6 Bn by 2028.
Ear infection, an infection that occurs in the space behind the ear drum, is a common reason for seeking medical attention. When bacteria or viruses infect the trap fluid behind the ear drum, they cause pain and swelling/bulging of the ear drum. Acute otitis media, or a sudden infection in the middle ear, is the medical term for ear infection in the space between the ear drum. The most common childhood illness is a middle ear infection (other than a cold). According to Cleveland Clinic statistics, ear infections are most common in children aged 3 months to 3 years, and they last until the age of 8. Furthermore, 25% of all children suffer from recurring ear infections.
|Market||Ear Infection Treatment Market|
|Analysis Period||2017 - 2028|
|Forecast Data||2021 - 2028|
|Segments Covered||By Infection, By Cause, By Treatment Type, and By Region|
|Regional Scope||North America, Europe, Asia Pacific, Latin America, and Middle East & Africa|
|Key Companies Profiled||American Diagnostic Corporation, Heine USA Ltd., Pfizer Inc., Medtronic, Torque Pharmaceuticals Pvt. Ltd., Intersect ENT, Inc., Olympus Corporation, and among others|
||Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis|
|Customization Scope||10 hrs of free customization and expert consultation|
Research and development activities develop a new technique to treat middle ear infections
According to a report released by the American Association for the Advancement of Science (AAAS), because middle ear infections affect more than 80% of children in the United States, researchers in a new study have designed a miniaturized 3D-printed device that inactivates Pseudomonas aeruginosa, a common bacterium responsible for the ear infection. The device is a micro plasma jet array that generates plasma made up of charged particles and reactive molecules that have been shown to render various pathogens inactive. This is the first time plasma technology has been used to treat middle ear infections.
Rising demand for surgeries fuel the growth of global ear infection treatment market
According to a Medtronic report, in order to keep children free of fluid buildup and infection, a doctor must perform surgery by inserting ventilation tubes in the ears or removing the adenoids (power-assisted adenoidectomy). The placement of tubes (vent tubes) or a power assisted adenoidectomy aids in the prevention of fluid buildup and infection in the ear. According to a Michigan Ear Institute report, eardrum grafting is successful in more than 90% of patients, resulting in a healed and dry ear. According to a report by The Nemours Foundation, ear tubes are successful in preventing chronic ear infections, but tubes are not always a permanent cure for otitis media. Up to 25 percent of children who require ear tubes before the age of two may need them again.
High government involvement and support stimulate the growth of global ear infection treatment market
According to a Commonwealth of Australia report, approximately 3.6 million Australians suffer from hearing loss. The Australian Government Hearing Services Program works tirelessly to reduce the occurrences and consequences of preventable hearing loss in the Australian community. This entails providing high-quality hearing services and devices to those who qualify. Furthermore, the Medical Research Future Fund provides funding with the goal of eliminating preventable hearing loss in Aboriginal and Torres Strait Islander children. Apart from that, according to the Queensland Health report, IUIH has grown tremendously over the last six years and now supports a network of 18 hospitals. Such factors have stimulated the growth of global ear infection treatment market.
The global ear infection treatment market is segmented as infection, cause, treatment type. Based on infection, the market is segmented as inner ear, middle ear, and outer ear. By cause, the market is segregated as bacterial infection, viral infection, and others. By treatment type, the market is segregated as drugs, surgery, and topical.
Bacterial infection accounts for a significant share of the global ear infection treatment market. According to the American Academy of Family Physicians, bacteria are responsible for 98% of cases of acute otitis externa in North America. Pseudomonas aeruginosa and Staphylococcus aureus are the two most common bacteria that cause ear infections. Such factors have positive influence on the segmental growth ultimately contributing for the growth of global ear infection treatment market.
The topical segment will account for the majority of the global ear infection treatment market. The mainstay of treatment for uncomplicated acute otitis externa is topical antimicrobials with or without topical corticosteroids. Topical antimicrobials have been shown to be highly effective when compared to placebo, with a 46% increase in cure rate for ear infection treatment market.
North America dominates; Asia Pacific to register fastest growing CAGR for the ear infection treatment market
North America has held the dominating share of the ear infection treatment market in the past and is expected to do so again during the forecast period. Because the healthcare sector in the United States is made up of a diverse range of clinicians, hospitals, varied healthcare facilities, insurance plans, and purchasers of healthcare services, it has risen to the top of the market. Furthermore, the majority of Americans have health insurance, either through a private plan or through a publicly funded program, which contributes to the growth of the ear infection treatment market. Furthermore, government support for early screening programs and ear infection diagnosis has a positive impact on the growth of the ear infection treatment market.
Asia Pacific, on the other hand, is expected to have the fastest growing CAGR in the ear infection treatment market in the coming years due to high prevalence of ear infection in APAC countries, 3.25% in Thailand, 12.23% in the Philippines, and 42% among Aboriginal Australian children. The APAC ear infection treatment market is growing due to strong government support and involvement. According to a report released by the Commonwealth of Australia, the Australian Government funds Aboriginal Medical Services. Furthermore, the government is involved in the development of skills and knowledge that aid in the prevention and treatment of ear disease and hearing loss. This is one of the major factors driving the growth of the Asia Pacific ear infection treatment market.
The prominent players of the global ear infection treatment market involve American Diagnostic Corporation, Heine USA Ltd., Pfizer Inc., Medtronic, Torque Pharmaceuticals Pvt. Ltd., Intersect ENT, Inc., Olympus Corporation, and among others
Market By Infection
Market By Cause
Market By Treatment Type
Market By Geography
• Rest of Europe
• South Korea
• Rest of Asia-Pacific
• Rest of Latin America
Middle East & Africa
• South Africa
• Rest of Middle East & Africa
Ear infection treatment market is expected to reach a market value of around US$ 9.6 Bn by 2028.
The ear infection treatment market is expected to grow at a CAGR of around 8.5% from 2021 to 2028.
Based on cause, bacterial infection segment is the leading segment in the overall market.
High government involvement is one of the prominent factors that drive the demand for ear infection treatment market.
American Diagnostic Corporation, Pfizer Inc., Heine USA Ltd., Torque Pharmaceuticals Pvt. Ltd., Medtronic, Intersect ENT, Inc., Olympus Corporation, and among others.
North America is anticipated to grab the highest market share in the regional market
Asia Pacific is expected to be the fastest growing market in the forthcoming years